Copyright
©The Author(s) 2017.
World J Gastroenterol. Dec 21, 2017; 23(47): 8376-8386
Published online Dec 21, 2017. doi: 10.3748/wjg.v23.i47.8376
Published online Dec 21, 2017. doi: 10.3748/wjg.v23.i47.8376
Table 5 Site of recurrence after surgery
| Site of recurrence | TA-NLR | ||
| ≤ 0.21(n = 71) | > 0.21(n = 71) | P value | |
| Liver | 10 | 28 | 0.001 |
| Peritoneal cavity | 6 | 9 | 0.413 |
| Lymph node | 2 | 11 | 0.009 |
| Lung | 3 | 4 | 0.721 |
| Bone | 0 | 5 | 0.058 |
| Adrenal gland | 1 | 4 | 0.366 |
| Pancreas | 2 | 2 | 1.000 |
| Locoregional recurrence | 2 | 3 | 0.683 |
| Spleen | 0 | 2 | 0.496 |
| Kidney | 1 | 1 | 1.000 |
| Brain | 0 | 1 | 1.000 |
| Number of patients with recurrence | 15 | 38 | < 0.001 |
- Citation: Cao LL, Lu J, Lin JX, Zheng CH, Li P, Xie JW, Wang JB, Chen QY, Lin M, Tu RH, Huang CM. Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms. World J Gastroenterol 2017; 23(47): 8376-8386
- URL: https://www.wjgnet.com/1007-9327/full/v23/i47/8376.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i47.8376